Phlorofucofuroeckol B suppresses inflammatory responses by down-regulating nuclear factor κB activation via Akt, ERK, and JNK in LPS-stimulated microglial cells

Int Immunopharmacol. 2015 Oct;28(2):1068-75. doi: 10.1016/j.intimp.2015.08.028. Epub 2015 Sep 2.

Abstract

Microglial activation has been implicated in many neurological disorders for its inflammatory and neurotrophic effects. In this study, we investigated the effects of phlorofucofuroeckol B (PFF-B) isolated from Ecklonia stolonifera, on the production of inflammatory mediators in lipopolysaccharide (LPS)-stimulated microglia. PFF-B decreased secretion of pro-inflammatory cytokines including tumor necrosis factor α, interleukin (IL)-1β, and IL-6 and the expression of pro-inflammatory proteins such as cyclooxygenase-2 and inducible nitric oxide synthase in LPS-stimulated BV-2 cells. Profoundly, PFF-B inhibited activation of nuclear factor kappaB (NF-κB) by preventing the degradation of inhibitor κB-α (IκB-α), which led to prevent the nuclear translocation of p65 NF-κB subunit. Moreover, PFF-B inhibited the phosphorylation of Akt, ERK, and JNK. These results indicate that the anti-inflammatory effect of PFF-B on LPS-stimulated microglial cells is mainly regulated by the inhibition of IκB-α/NF-κB and Akt/ERK/JNK pathways. Our study suggests that PFF-B can be considered as a therapeutic agent against neuroinflammation by inhibiting microglial activation.

Keywords: Ecklonia stolonifera; Microglia; Neuroinflammation; Nuclear factor-κB; Phlorofucofuroeckol B.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Benzofurans / isolation & purification
  • Benzofurans / pharmacology*
  • Cell Line
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • Cytokines / metabolism
  • Dioxins / isolation & purification
  • Dioxins / pharmacology*
  • Down-Regulation / drug effects
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Immunosuppressive Agents / pharmacology*
  • Inflammation Mediators / metabolism
  • Lipopolysaccharides / immunology
  • MAP Kinase Kinase 4 / metabolism
  • Mice
  • Microglia / cytology
  • Microglia / drug effects*
  • Microglia / metabolism
  • NF-kappa B / metabolism*
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism
  • Oncogene Protein v-akt / metabolism
  • Phaeophyceae / immunology
  • Signal Transduction / drug effects
  • Transcriptional Activation / drug effects

Substances

  • Anti-Inflammatory Agents
  • Benzofurans
  • Cytokines
  • Dioxins
  • Immunosuppressive Agents
  • Inflammation Mediators
  • Lipopolysaccharides
  • NF-kappa B
  • phlorofucofuroeckol B
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Oncogene Protein v-akt
  • Extracellular Signal-Regulated MAP Kinases
  • MAP Kinase Kinase 4